Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
NCT00598429Phase 2Withdrawn
- Sponsor
- NICHD Neonatal Research Network
- Start
- May 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Vasostenoon in hypoxemic respiratory failure (3 arms), sponsored by NICHD Neonatal Research Network. Primary endpoint: Ability to recruit an adequate number of patients. Planned start May 2008; status: withdrawn.
02
Drugs
Vasostenoon
03
Conditions
hypoxemic respiratory failure
Beyond the preview
Go deeper on NCT00598429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598429.